REFLUSEN L

Dénomination commerciale

REFLUSEN L

D-FT.CE.107.FB.8.CAMPRF

B-FT.CE.107.FB.8.CAMPRF

Numéro de référence/catalogue

FT.CE.107.FB.8.CAMP

EUDAMED

Classe IIa

Législation applicable

MDD [Directive 93/42/CEE relative aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

REFLUSEN è un dispositivo medico utile nel trattamento sintomatologico di tutti quegli stati legati al reflusso gastro-esofageo (NERD, Pirosi funzionale, esofago ipersensibile al reflusso acido e non acido). La sua formulazione viscosa, capace di aderire e ricoprire la mucosa esofagea, forma una barriera protettiva. L’acido ialuronico, componente naturalmente presente nelle matrici extracellulari del nostro organismo, idrata e protegge le mucose del tratto gastro-esofageo e coadiuva il processo di ricostruzione dell’epitelio danneggiato. Il Magnesio Alginato, grazie alle sue proprietà filmanti, riveste le mucose proteggendole dai succhi gastrici contribuendo alla riduzione degli effetti nocivi degli stessi e alla sensazione di bruciore ed irritazione dovuti ad episodi di reflusso.

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• G0401ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS

1 avertissement enregistré — faire défiler le panneau pour tout voir.

• Keep out of reach of children. Avoid contact with eyes. In case of concomitant therapy with other drugs and / or medical devices, consult your doctor before using the product. Do not use the product after the expiration date; the expiry date refers to the intact and properly stored product. For pregnant and lactating women, the use of the product should be limited to cases of real need and under the direct supervision of the doctor. Do not use in case of individual hypersensitivity to the present components. Do not use the product in association with quaternary ammonium compounds. Do not use the product for a period exceeding 30 consecutive days. It is important to inform your doctor or pharmacist of any side eects not described in this package insert. Single-dose product to be used in a single administration. The incorrect observance of the warnings and of the methods of use, as well as the use of a partial dose of the product, could prejudice its eectiveness or be the cause of the aggravation of the existing pathological situation.

  AUTRE